TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,144,336 | -8.1% | 267,895 | -6.7% | 0.00% | -20.0% |
Q2 2023 | $4,510,639 | -33.3% | 287,119 | -30.0% | 0.01% | -28.6% |
Q1 2023 | $6,763,623 | +98.7% | 410,414 | +72.6% | 0.01% | +133.3% |
Q1 2022 | $3,404,000 | +31.2% | 237,726 | +24.9% | 0.00% | +50.0% |
Q4 2021 | $2,594,000 | +850.2% | 190,311 | +1168.7% | 0.00% | – |
Q4 2020 | $273,000 | +1.9% | 15,000 | 0.0% | 0.00% | – |
Q3 2020 | $268,000 | -0.4% | 15,000 | 0.0% | 0.00% | – |
Q2 2020 | $269,000 | -91.1% | 15,000 | -92.5% | 0.00% | -100.0% |
Q1 2020 | $3,037,000 | -80.5% | 200,080 | -74.7% | 0.01% | -72.2% |
Q4 2019 | $15,608,000 | -59.8% | 791,110 | -64.9% | 0.02% | -61.7% |
Q3 2019 | $38,812,000 | +50.5% | 2,256,527 | +54.9% | 0.05% | +42.4% |
Q2 2019 | $25,781,000 | +121.8% | 1,456,560 | +155.3% | 0.03% | +120.0% |
Q1 2019 | $11,621,000 | – | 570,477 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |